Skip to main content

SOP

Glycated Hemoglobin (HbA1c) Testing

SOP for measuring HbA1c to monitor long-term glycemic control in diabetes.

Last verified 1 month ago 1 min read Clinical Chemistry Endocrinology Diabetes #diabetes #hba1c #glycated hemoglobin #hplc #endocrinology
Link copied!
Document Control
Version
1.0
Effective
Aug 29, 2026
Reviewed
Aug 29, 2026
Department
Clinical Chemistry / Endocrinology
Principle

Glucose non-enzymatically binds to the N-terminal valine of the hemoglobin beta chain. HPLC separates HbA1c from other hemoglobin fractions based on charge differences, providing a highly specific and standardized measurement.

Standard Operating Procedure: HbA1c Testing

1. Purpose: Monitor 2-3 month average blood glucose levels in diabetic patients.

2. Specimen: Whole blood (EDTA preferred).

3. Reagents: HPLC buffers or immunoturbidimetric reagents (NGSP-certified methods).

4. Procedure (HPLC Method):

  • Hemolyze whole blood sample.
  • Inject into cation-exchange HPLC column.
  • HbA1c elutes at a specific retention time due to its altered charge.
  • Quantify via spectrophotometric detection, reporting as % of total hemoglobin.

5. Reference Ranges

  • The canonical adult reference interval for HbA1c is shown in the Reference Ranges panel below.

Decision Limits (ADA diagnostic categories)

  • Normal: < 5.7%
  • Prediabetes: 5.7-6.4%
  • Diabetes: ≥ 6.5%

6. QC: Run 2 levels of NGSP-certified HbA1c controls daily.

Reference Ranges

Browse all ranges

Frequently Asked Questions

Hemoglobin variants (e.g., HbS, HbC), severe anemia, recent blood transfusion, or conditions altering RBC lifespan (e.g., hemolysis, ESRD).